It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Childhood radiation exposure is a known thyroid cancer risk factor. This study evaluated the effects of age on radiation-induced thyroid carcinogenesis in rats irradiated with 8 Gy X-rays. We analyzed cell proliferation, cell death, DNA damage response, and autophagy-related markers in 4-week-old (4W) and 7-month-old (7M) rats and the incidence of thyroid tumors in 4W, 4-month-old (4M), and 7M rats 18 months after irradiation. Cell death and DNA damage response were increased in 4W rats compared to those in controls at 1 month post-irradiation. More Ki-67-positive cells were observed in 4W rats at 12 months post-irradiation. Thyroid tumors were confirmed in 61.9% (13/21), 63.6% (7/11), and 33.3% (2/6) of irradiated 4W, 4M, and 7M rats, respectively, compared to 0%, 14.3% (1/7), and 16.7% (1/6) in the respective nonirradiated controls. There were 29, 9, and 2 tumors in irradiated 4W, 4M, and 7M rats, respectively. The expression of several autophagy components was downregulated in the area surrounding radiation-induced thyroid carcinomas in 4W and 7M rats. LC3 and p62 expression levels decreased in radiation-induced follicular carcinoma in 4W rats. Radiosensitive cells causing thyroid tumors may be more prevalent in young rats, and abrogation of autophagy may be associated with radiation-induced thyroid carcinogenesis.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Nagasaki University, Tissue and Histopathology Section, Atomic Bomb Disease Institute, Nagasaki, Japan (GRID:grid.174567.6) (ISNI:0000 0000 8902 2273)
2 Nagasaki University, Department of Tumor and Diagnostic Pathology, Atomic Bomb Disease Institute, Nagasaki, Japan (GRID:grid.174567.6) (ISNI:0000 0000 8902 2273)
3 Hiroshima University, Department of Disease Model, Research Institute for Radiation Biology and Medicine, Hiroshima, Japan (GRID:grid.257022.0) (ISNI:0000 0000 8711 3200)
4 Nagasaki University, Biostatistics Section, Atomic Bomb Disease Institute, Nagasaki, Japan (GRID:grid.174567.6) (ISNI:0000 0000 8902 2273)
5 National Hospital Organization Nagasaki Medical Center, Ōmura, Japan (GRID:grid.415640.2)
6 Nagasaki University, Department of Molecular Medicine, Atomic Bomb Disease Institute, Nagasaki, Japan (GRID:grid.174567.6) (ISNI:0000 0000 8902 2273)
7 Nagasaki University, Tissue and Histopathology Section, Atomic Bomb Disease Institute, Nagasaki, Japan (GRID:grid.174567.6) (ISNI:0000 0000 8902 2273); Nagasaki University, Department of Tumor and Diagnostic Pathology, Atomic Bomb Disease Institute, Nagasaki, Japan (GRID:grid.174567.6) (ISNI:0000 0000 8902 2273)